TY - JOUR T1 - Assessment of Machine Learning Algorithms for Prediction of Breast Cancer Malignancy Based on Mammogram Numeric Data JF - medRxiv DO - 10.1101/2020.01.08.20016949 SP - 2020.01.08.20016949 AU - Peter T. Habib AU - Alsamman M. Alsamman AU - Sameh E. Hassnein AU - Ghada A. Shereif AU - Aladdin Hamwieh Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/01/10/2020.01.08.20016949.abstract N2 - in 2019, estimated New Cases 268.600, Breast cancer has one of the most common cancers and is one of the world’s leading causes of death for women. Classification and data mining is an efficient way to classify information. Particularly in the medical field where prediction techniques are commonly used for early detection and effective treatment in diagnosis and research.These paper tests models for the mammogram analysis of breast cancer information from 23 of the more widely used machine learning algorithms such as Decision Tree, Random forest, K-nearest neighbors and support vector machine. The spontaneously splits results are distributed from a replicated 10-fold cross-validation method. The accuracy calculated by Regression Metrics such as Mean Absolute Error, Mean Squared Error, R2 Score and Clustering Metrics such as Adjusted Rand Index, Homogeneity, V-measure.accuracy has been checked F-Measure, AUC, and Cross-Validation. Thus, proper identification of patients with breast cancer would create care opportunities, for example, the supervision and the implementation of intervention plans could benefit the quality of long-term care. Experimental results reveal that the maximum precision 100%with the lowest error rate is obtained with Ada-boost Classifier.Competing Interest StatementThe authors have declared no competing interest.Funding Statementauthors did not receive any fundsAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://github.com/peterhabib/EvaluationOfML/tree/master ER -